Gene therapy in the inner ear: Mechanisms and clinical implications

Annals of the New York Academy of Sciences

Volumn 884, Issue , 1999, Pages 345-360

  Van De Water, Thomas R ^a   Staecker, Hinrich ^a,b   Halterman, Marc W ^c   Federoff, Howard J ^c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GALACTOSIDASE; LIPOSOME; NEUROTROPHIN; NEUROTROPHIN 3; VIRUS VECTOR;

ACOUSTIC NERVE FIBER; ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL SURVIVAL; CLONING VECTOR; COCHLEA; COCHLEA INJURY; CONFERENCE PAPER; CONTROLLED STUDY; GENE THERAPY; GENETIC TRANSDUCTION; MARKER GENE; NONHUMAN; OTOTOXICITY; RETROVIRUS;

EID: 0032787488     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08653.x     Document Type: Conference Paper

References (27)

1. 1. Chiocca, S. & M. Cotton. 1998. Characteristics of adenovirus vectors. In Gene Therapy for Neurological Disorders and Brain Tumors, E. Chiocca and X. Breakfield, Eds.: 39-51.
2. 2. Ernfors, P., T. R. Van De Water, J. Loring & R. Jaenisch. 1995. Complementary roles of BDNF and NT-3 in auditory and vestibular development. Neuron 14: 1153-1164.
3. 3. Felgner, P. L. 1996. Improvements in cationic liposomes for in vivo gene transfer. Hum. Gene Ther. 7: 1791-1793.
4. 4. Fink, D., N. DeLuca, W. Goins & J. Glorioso. 1996. Gene transfer to neurons using herpes simplex based vectors. Ann. Rev. Neurosci. 19: 265-287.
5. 5. Gabaizadeh, R., H. Staecker, W. Liu & T. R. Van De Water. 1997. BDNF protection of auditory neurons from cisplatin involves changes in intracellular levels of both reactive oxygen species and glutathione. Mol. Brain Res. 50: 71-78.
6. 6. Geschwind, M., C. Hartnick, W. Liu, J. Amat, T. R. Van De Water & H. Federoff. 1996. Defective HSV-1 vector expressing BDNF in auditory ganglia elicits neurite outgrowth: model for treatment of neuron loss following cochlear degeneration. Hum. Gene Ther. 7: 173-182.
7. 7. Lalwani, A. K., B. J. Walsh, P. G. Reilly, N. Muzyczka & A. N. Mhatre. 1996. Development of in vivo gene therapy for hearing disorders: introduction of adeno-associated virus into the cochlea of the guinea pig. Gene Ther. 3: 588-592.
8. 8. Lalwani, A. K., J. J. Han, B. J. Walsh, S. Zolotukhin, N. Muzyczka & A. N. Mhatre. 1997. Green fluorescent protein as a reporter for gene transfer studies in the cochlea. Hear. Res. 114: 139-147.
9. 9. Lalwani, A. K., B. J. Walsh, G. J. Carvalho, N. Muzyczka & A. Mhatre. 1998. Expression of adeno-associated virus integrated transgene within the mammalian vestibular organs. Am. J. Otol. 19: 390-395.
10. 10. Lalwani, A., B. Walsh, P. Reilly, G. Carvalho, S. Zolotukhin, N. Muzyczka & A. Mhatre. 1998. Long-term in vivo cochlear transgene expression mediated by recombinant adeno-associated virus. Gene Ther. 5: 277-281.
11. 11. Lefebvre, P. P., B. Malgrange, H. Staecker, M. Moghadassi, T. R. Van De Water & G. Moonen. 1994. Neurotrophins affect survival and neuritogenesis by adult injured auditory neurons in vitro. NeuroReport 14: 865-868.
12. 12. Lewin, G. & Y.-A. Barde. 1996. Physiology of the neurotrophins. Annu. Rev. Neurosci. 19: 289-317.
13. 13. Malgrange, B., P. Lefebvre, T. R. Van De Water, H. Staecker & G. Moonen. 1996. Effects of neurotrophins on early postnatal auditory neurons in culture. NeuroReport 7: 913-917.
14. 14. Petit, C. 1996. Genes responsible for human deafness: symphony of a thousand. Nature Genet. 14: 385-391.
15. 15. Raphael, Y., J. C. Frisancho & B. J. Roessler. 1996. Adenoviral-mediated gene transfer into guinea pig cochlear cells in vivo. Neurosci. Lett. 207: 137-141.
16. 16. Reeves, S. 1998. Retrovirus vectors and regulatable promoters. In Gene Therapy for Neurological Disorders and Brain Tumors, E. Chiocca and X. Breakfield, Eds.: 7-38. Humana Press. Totowa, N.J.
17. 17. Samulski, R. 1993. Adeno-associated virus: integrational at a specific chromosomal locus. Curr. Opin. Genes Dev. 3: 74-80.
18. 18. Smith, F. & T. McCown. 1998. AAV Vectors. In Gene Therapy for Neurological Disorders and Brain Tumors, E. Chiocca and X. Breakfield, Eds.: 83-92. Humana Press. Totowa, N.J.
19. 19. Spoendlin, H. 1971. Degeneration behavior of the cochlear nerve. Arch. Klin. Exp. Ohren-Nasen Kehlkopfheilk. 200: 275-291.
20. 20. Spoendlin, H. 1988. Biology of the vestibulocochlear nerve. In Otologic Medicine and Surgery, Vol. 1, P. W. Albert and R. J. Ruben, Eds.: 117-150. Churchill Livingstone. New York.
21. 21. Staecker, H., V. Galinovic-Schwartz, W. Liu, P. Lefebvre, R. Kopke, B. Malgrange, G. Moonen & T. R. Van De Water. 1996. The role of neurotrophins in maturation and maintenance of postnatal auditory neurons. Am. J. Otol. 17: 486-492.
22. 22. Staecker, H., T. R. Van De Water, P. Lefebvre, W. Liu, M. Moghadassi, V. Galinovic-Schwartz, B. Malgrange & G. Monnen. 1996. NGF, BDNF and NT-3 play unique roles in the in vitro development and patterning of innervation of the mammalian inner ear. Dev. Brain Res. 92: 49-60.
23. 23. Staecker, H., R. Kopke, B. Malgrange, P. Lefebvre & T. R. Van De Water. 1996. NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. NeuroReport 7: 889-894.
24. 24. Staecker, H., R. Gabaizadeh, H. Federoff & T. R. Van De Water. 1998. Brain derived neurotrophic factor gene therapy prevents degeneration of spiral ganglion neurons in a mouse model of aminglycoside ototoxicity. Otolaryngol. Head Neck Surg. 119: 7-13.
25. 25. Wagner, R. 1994. Gene inhibition using antisense oligonucleotides. Nature 24: 333-336.
26. 26. Weiss, M. A., J. C. Frisancho, B. J. Roessler & Y. Raphael. 1997. Viral-mediated gene transfer in the cochlea. Int. J. Dev. Neurosci. 15: 577-583.
27. 27. Ylikoski, J., U. Pirvola, M. Moshnyakov, J. Palgi, U. Arumae & M. Saarma. 1993. Expression patterns of neurotrophin and their receptor mRNAs in the rat inner ear. Hear. Res. 65: 69-78.